Cite

HARVARD Citation

    Crowley, S. et al. (2020). Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH. Open biology. 10 (2), p. . [Online]. 
  
Back to record